107 related articles for article (PubMed ID: 16827156)
1. Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines.
Tanic N; Brkic G; Dimitrijevic B; Dedovic-Tanic N; Gefen N; Benharroch D; Gopas J
Anticancer Res; 2006; 26(3A):2137-42. PubMed ID: 16827156
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability in drug-resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR.
Brkic G; Gopas J; Tanic N; Dedovic-Tanic N; Benharroch D; Finkelstein-Jaworowsky E; Kedar I; Dimitrijevic B
Anticancer Res; 2003; 23(3B):2601-8. PubMed ID: 12894547
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells.
Simon HG; Risse B; Jost M; Oppenheimer S; Kari C; Rodeck U
Cancer Res; 1996 Jul; 56(13):3112-7. PubMed ID: 8674069
[TBL] [Abstract][Full Text] [Related]
4. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
5. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
7. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization.
Boukerche H; Su ZZ; Kang DC; Fisher PB
Gene; 2004 Dec; 343(1):191-201. PubMed ID: 15563845
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
9. [Cloning of drug resistance-related gene fragments differentially expressed on lung adenocarcinoma cell line A549 and its DDP-resistant counterpart A549DDP].
Wang J; Liu X; Li Z
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):107-10. PubMed ID: 11783011
[TBL] [Abstract][Full Text] [Related]
10. Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activity.
Kocher T; Schraml P; Spagnoli GC; Harder F; Heberer M
Schweiz Med Wochenschr; 2000 Apr; 130(17):617-24. PubMed ID: 10829299
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative reverse transcriptase-polymerase chain reaction analysis of melanoma progression-associated genes.
Rafferty M; Faller WJ; Moss C; McCormack J; Mãlandsmo GM; Easty DJ; Gallagher WM
Anticancer Res; 2007; 27(3A):1301-7. PubMed ID: 17593623
[TBL] [Abstract][Full Text] [Related]
12. Novel gene sequences expressed by human melanoma cells identified by molecular subtraction.
Hutchins JT; Deans RJ; Mitchell MS; Uchiyama C; Kan-Mitchell J
Cancer Res; 1991 Mar; 51(5):1418-25. PubMed ID: 1997180
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
[TBL] [Abstract][Full Text] [Related]
14. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma.
Feller AJ; Duan Z; Penson R; Toh HC; Seiden MV
Anticancer Res; 2000; 20(6B):4147-51. PubMed ID: 11205240
[TBL] [Abstract][Full Text] [Related]
15. Loss of oncostatin M receptor beta in metastatic melanoma cells.
Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F
Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
[TBL] [Abstract][Full Text] [Related]
17. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
18. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
19. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
[TBL] [Abstract][Full Text] [Related]
20. Multiplex reverse transcription-polymerase chain reaction combined with on-chip electrophoresis as a rapid screening tool for candidate gene sets.
Wittig R; Salowsky R; Blaich S; Lyer S; Maa JS; Müller O; Mollenhauer J; Poustka A
Electrophoresis; 2005 May; 26(9):1687-91. PubMed ID: 15812845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
